CRISPR

CRISPR4-lepr

ID
ZDB-CRISPR-190718-1
Name
CRISPR4-lepr
Previous Names
None
Target
Sequence
5' - GGGCTGACGCTGACCAGAG - 3'
ZFIN BLAST NCBI BLAST Ensembl
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
umo39 lepr
zf3068 lepr
zf3583 lepr
Expression
Gene expression in Wild Types + CRISPR4-lepr
No data available
Phenotype
Phenotype resulting from CRISPR4-lepr
No data available
Phenotype of all Fish created by or utilizing CRISPR4-lepr
Phenotype Fish Conditions Figures
muscle lepr expression decreased amount, abnormal leprumo39/umo39 (AB) standard conditions Fig. 1 from Hu et al., 2022
male organism liver lepr expression decreased amount, abnormal leprzf3068/zf3068 standard conditions Fig. 4 with image from Yang et al., 2019
eating behavior increased frequency, abnormal leprzf3068/zf3068 increased food availability Fig. 2 from Fei et al., 2017
whole organism fatty, abnormal leprzf3068/zf3068 increased food availability Fig. 2 from Fei et al., 2017
whole organism increased weight, abnormal leprzf3068/zf3068 increased food availability Fig. 2 from Fei et al., 2017
male organism decreased weight, abnormal leprzf3068/zf3068 standard conditions Fig. 4 with image from Yang et al., 2019
feeding behavior behavioral quality of a process, abnormal leprzf3068/zf3068 increased food availability Fig. 2 from Fei et al., 2017
male organism skeletal muscle decreased mass, abnormal leprzf3068/zf3068 standard conditions Fig. 4 with image from Yang et al., 2019
male organism liver lepr expression decreased amount, abnormal leprzf3068/+ standard conditions Fig. 4 with image from Yang et al., 2019
male organism decreased weight, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism decreased life span, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
male organism liver neoplastic, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism skeletal muscle decreased mass, ameliorated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism decreased life span, ameliorated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism skeletal muscle decreased mass, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism hepatocellular carcinoma increased amount, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
hepatocyte cell population proliferation increased occurrence, exacerbated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism decreased life span, abnormal leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 4 with image from Yang et al., 2019
male organism liver neoplastic, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
male organism decreased weight, abnormal leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism hepatocellular carcinoma increased amount, ameliorated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism skeletal muscle decreased mass, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
male organism decreased weight, abnormal leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism decreased life span, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism liver neoplastic, ameliorated leprzf3068/+; gz32Tg increased food availability, chemical treatment by environment: doxycycline Fig. 5 with image from Yang et al., 2019
male organism hepatocellular carcinoma increased amount, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
hepatocyte cell population proliferation increased occurrence, abnormal leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline Fig. 5 with image,  Fig. 6 with image from Yang et al., 2019
hepatocyte cell population proliferation increased occurrence, ameliorated leprzf3068/+; gz32Tg chemical treatment by environment: doxycycline, limited food availability Fig. 5 with image from Yang et al., 2019
male organism decreased life span, exacerbated leprzf3068/zf3068; gz32Tg chemical treatment by environment: doxycycline Fig. 4 with image from Yang et al., 2019
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.